Trials / Completed
CompletedNCT05695742
Smoking Cessation Outcomes and Effective Factors
Smoking Cessation Outcomes and Effective Factors: Maximal Voluntary Breath-holding Time and Exercise Capacity
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 893 (actual)
- Sponsor
- Saglik Bilimleri Universitesi · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
The study is a cross-sectional-descriptive study. Cases who met the inclusion criteria, agreed to participate in the study voluntarily, were active smokers, passive smokers and non-smokers will be included. The subjects will be given the maximal voluntary breath-hold test, the 6-minute walk test, and the 30-second sit-and-stand test, and will be asked to answer questions about smoking. The physical conditions of the groups will be compared.
Detailed description
The study is a cross-sectional-descriptive study. Cases who met the inclusion criteria, agreed to participate in the study voluntarily, were active smokers, passive smokers and non-smokers will be included. Active smoking, passive smoking status and non-smoker status of the cases will be determined within the framework of the definitions given below. * Active smoker: Having smoked at least 1 cigarette per day for at least 2 years. * Passive smoker: Being exposed to secondhand smoke for more than 15 minutes at home, school, office or anywhere in the past year, once a week. * Non-smoker: Not being an active or passive smoker. The subjects will be given the maximal voluntary breath-hold test, the 6-minute walk test, and the 30-second sit-and-stand test, and will be asked to answer questions about smoking.The physical conditions of the groups will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Active Smoking | Being active smoker |
| OTHER | Passive smoker | Being exposed to secondhand smoke |
| OTHER | Non-smoker | Not being an active or passive smoker. |
Timeline
- Start date
- 2023-01-23
- Primary completion
- 2023-09-27
- Completion
- 2023-09-27
- First posted
- 2023-01-25
- Last updated
- 2023-10-06
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05695742. Inclusion in this directory is not an endorsement.